Literature DB >> 35506244

Predictors of Incident Serrated Polyps: Results from a Large Multicenter Clinical Trial.

Seth D Crockett1, Elizabeth L Barry2, Leila A Mott2, Dale C Snover3, Kristin Wallace4, John A Baron1.   

Abstract

BACKGROUND: Serrated polyps (SP) are important colorectal cancer precursors, yet their epidemiology is incompletely understood. We measured risk factors for incident sessile-serrated lesions (SSL) and microvesicular (MVHP) and goblet-cell rich (GCHP) hyperplastic polyp subtypes.
METHODS: We conducted a cohort study of patients undergoing colonoscopic surveillance nested within a chemoprevention trial. Outcomes of interest were ≥1 SPs, including SSLs, MVHPs, and GCHPs specifically. Multivariable generalized estimating equation models were used to estimate adjusted risk ratios (RR) and 95% confidence intervals (CI) for different polyp types.
RESULTS: Among 2,102 participants, a total of 1,615 SPs (including 212 SSLs) were found among 758 participants during follow-up. Prior history of SPs was strongly associated with subsequent occurrence of SPs. There was no apparent association between age, sex, or education and risk of SPs. Black participants were at lower risk of SSLs and MVHPs, but higher risk of GCHPs compared with white participants [RR, 0.40; 95% CI, 0.16-0.99); RR, 0.63 (95% CI, 0.42-0.96); and RR, 1.83 (95% CI, 1.23-2.72) respectively]. Alcohol and smoking exposure were also associated with SPs, including hyperplastic polyp subtypes in particular.
CONCLUSIONS: In this prospective study, the risk of SP subtypes differed by race, alcohol, and smoking status, and prior history of SPs. Risk factor associations for SPs differ from risk factors for conventional adenomas, supporting the concept of etiologic heterogeneity of colorectal cancer. IMPACT: These findings allow for better risk stratification of patients undergoing colorectal cancer screening and could inform screening test selection. ©2022 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2022        PMID: 35506244      PMCID: PMC9074097          DOI: 10.1158/1055-9965.EPI-21-1226

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  51 in total

Review 1.  Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.

Authors:  Anne F Peery; Seth D Crockett; Caitlin C Murphy; Jennifer L Lund; Evan S Dellon; J Lucas Williams; Elizabeth T Jensen; Nicholas J Shaheen; Alfred S Barritt; Sarah R Lieber; Bharati Kochar; Edward L Barnes; Y Claire Fan; Virginia Pate; Joseph Galanko; Todd H Baron; Robert S Sandler
Journal:  Gastroenterology       Date:  2018-10-10       Impact factor: 22.682

2.  Higher prevalence of proximal colon polyps and villous histology in African-Americans undergoing colonoscopy at a single equal access center.

Authors:  Christian S Jackson; Kenneth J Vega
Journal:  J Gastrointest Oncol       Date:  2015-12

3.  Endoscopist factors that influence serrated polyp detection: a multicenter study.

Authors:  Seth D Crockett; Rebecca A Gourevitch; Michele Morris; David S Carrell; Sherri Rose; Zhuo Shi; Julia B Greer; Robert E Schoen; Ateev Mehrotra
Journal:  Endoscopy       Date:  2018-04-24       Impact factor: 10.093

4.  Race and Prevalence of Large Bowel Polyps Among the Low-Income and Uninsured in South Carolina.

Authors:  Kristin Wallace; Heather M Brandt; James D Bearden; Bridgette F Blankenship; Renay Caldwell; James Dunn; Patricia Hegedus; Brenda J Hoffman; Courtney H Marsh; William H Marsh; Cathy L Melvin; March E Seabrook; Ronald E Sterba; Mary Lou Stinson; Annie Thibault; Franklin G Berger; Anthony J Alberg
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

5.  Variation Over Time and Factors Associated With Detection Rates of Sessile Serrated Lesion Across the United States: Results Form a National Sample Using the GIQuIC Registry.

Authors:  Aasma Shaukat; Jennifer Holub; David Greenwald; Glenn Eisen; Colleen Schmitt
Journal:  Am J Gastroenterol       Date:  2021-01-01       Impact factor: 10.864

6.  Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs.

Authors:  Douglas A Corley; Christopher D Jensen; Amy R Marks; Wei K Zhao; Jolanda de Boer; Theodore R Levin; Chyke Doubeni; Bruce H Fireman; Charles P Quesenberry
Journal:  Clin Gastroenterol Hepatol       Date:  2012-09-14       Impact factor: 11.382

7.  Prevalence, distribution and risk of sessile serrated adenomas/polyps at a center with a high adenoma detection rate and experienced pathologists.

Authors:  Joep E G IJspeert; Koos de Wit; Manon van der Vlugt; Barbara A J Bastiaansen; Paul Fockens; Evelien Dekker
Journal:  Endoscopy       Date:  2016-04-25       Impact factor: 10.093

8.  Smoking and Colorectal Cancer Risk, Overall and by Molecular Subtypes: A Meta-Analysis.

Authors:  Edoardo Botteri; Elisa Borroni; Erica K Sloan; Vincenzo Bagnardi; Cristina Bosetti; Giulia Peveri; Claudia Santucci; Claudia Specchia; Piet van den Brandt; Silvano Gallus; Alessandra Lugo
Journal:  Am J Gastroenterol       Date:  2020-12       Impact factor: 10.864

9.  Somatic gene mutations in African Americans may predict worse outcomes in colorectal cancer.

Authors:  Melissa Kang; Xiang J Shen; Sangmi Kim; Felix Araujo-Perez; Joseph A Galanko; Chris F Martin; Robert S Sandler; Temitope O Keku
Journal:  Cancer Biomark       Date:  2013       Impact factor: 4.388

10.  MicroRNA124-IL6R Mediates the Effect of Nicotine in Inflammatory Bowel Disease by Shifting Th1/Th2 Balance Toward Th1.

Authors:  Zhen Qin; Peng-Yuan Wang; Jing-Jing Wan; Yu Zhang; Jie Wei; Yang Sun; Xia Liu
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.